Skip to main content

Table 4 Effects of gamma irradiation on ESBL production by five ESBLs-producing bacterial strains

From: Natural outer membrane permeabilizers boost antibiotic action against irradiated resistant bacteria

Isolate No./ Species of microorganism

Radiation

Half of inhibition zone (mm) in absence AMC / adjacent to AMC disk (DDST)

Mean ± SD (SE)

Half of inhibition zone (mm) in absence TZP/adjacent to TZP disk (MDDT)

Mean ± SD (SE)

AMC

CTX

CAZ

FEP

ATM

TZP

CAZ

FEP

2/ Escherichia coli

Before

5.5 ± 0.5(0.3)

3 ± 0.5(0.3) /7 ± 0.5(0.3)

3 ± 0.3 (0.2)

/8 ± 0.6 (0.3)

3 ± 0.2 (0.1)

/3 ± 0.6 (0.3)

3 ± 0.8 (0.5)

/3 ± 0.1 (0.1)

7 ± 0.8 (0.5)

3 ± 0.2 (0.1)

/9 ± 0.2 (0.1)

3 ± 0.5(0.3)

/6 ± 0.5(0.3)

After

6 ± 0.5(0.3)

3 ± 0.2 (0.1)

/7 ± 0.2 (0.1)

3 ± 0.5(0.3)

/8 ± 0.7 (0.4)

5 ± 0.4 (0.2)

/5 ± 0.1 (0.1)

3 ± 0.5(0.3)

/3 ± 0.7 (0.4)

9 ± 0.2 (0.1)

3 ± 0.4 (0.2)

/9 ± 0.2 (0.1)

5 ± 0.3 (0.2)

/8 ± 0.2 (0.1)

% of change

8.3

0.0

/0.0

0.0

/0.0

40

/40

0.0

/0.0

22.2

0.0

/0.0

40

/25

(p-value)

0.288

1.000

/1.000

1.000

/1.000

<0.001**

/0.005*

1.000

/1.000

0.014*

1.000

/1.000

0.004*

/0.003*

4/ Acinetobacter baumannii

Before

5 ± 0.4 (0.2)

3 ± 0.5(0.3)

/3 ± 0.4 (0.2)

3 ± 0.2 (0.1)

/3 ± 0.4 (0.2)

3.5 ± 0.5(0.3)

/10 ± 0.6 (0.3)

3 ± 0.3 (0.2)

/7 ± 0.7 (0.4)

7.5 ± 0.5(0.3)

3 ± 0.7 (0.4)

/10 ± 0.2 (0.1)

3.5 ± 0.4 (0.2)

/3.5 ± 0.5(0.3)

After

5 ± 0.6 (0.3)

5 ± 0.3 (0.2)

/6 ± 0.6 (0.3)

5 ± 0.4 (0.2)

/6 ± 0.2 (0.1)

4 ± 0.5(0.3)

/11 ± 0.8 (0.5)

3 ± 0.8 (0.5)

/7 ± 0.2 (0.1)

9.5 ± 0.5(0.3)

5 ± 0.5(0.3)

/13 ± 0.4 (0.2)

4 ± 0.2 (0.1)

/5.5 ± 0.3 (0.2)

% of change

0.0

40

/50

40

/50

12.5

/9.1

0.0

/0.0

21.1

40

/23.1

12.5

/36.4

(p-value)

1.000

0.004*/

0.002*

<0.001**

/ <0.001**

0.288

/0.158

1.000

/1.000

0.008*

0.016*

/ <0.001**

0.125

/0.004*

8/ Pseudomonas aeruginosa

Before

3 ± 0.9 (0.5)

3 ± 0.2 (0.1)/3 ± 0.5(0.3)

4.5 ± 0.4 (0.2)

/10 ± 0.2 (0.1)

8 ± 0.4 (0.2)

/12 ± 0.2 (0.1)

6 ± 0.3 (0.2)

/6 ± 0.5(0.3)

8.5 ± 0.5(0.3)

4.5 ± 0.5(0.3)

/11 ± 0.2 (0.1)

8 ± 0.2 (0.1)

/12 ± 0.4 (0.2)

After

5 ± 0.3 (0.2)

5 ± 0.4 (0.2)/6 ± 0.2 (0.1)

6.5 ± 0.2 (0.1)/13 ± 0.5(0.3)

9 ± 0.2 (0.1)

/13.5 ± 0.5(0.3)

7 ± 0.4 (0.2)/8 ± 0.2 (0.1)

12 ± 0.3 (0.2)

6 ± 0.2 (0.1)

/13.5 ± 0.5(0.3)

9 ± 0.1 (0.1)

/14 ± 0.2 (0.1)

% of change

40

40

/50

30.8

/23.1

11.1

/11.1

14.3

/25

29.2

25

/18.5

11.1

/14.3

(p-value)

0.22*

<0.001**

/ <0.001**

<0.001**

/ <0.001**

0.018*

/0.008*

0.026*

/0.003*

<0.001**

0.008*

/ <0.001**

<0.001**

/ <0.001**

9/ Pseudomonas aeruginosa

Before

3 ± 0.3 (0.2)

3 ± 0.5(0.3)

/3 ± 0.2 (0.1)

3 ± 0.4 (0.2)

/9 ± 0.2 (0.1)

3 ± 0.2 (0.1)

/8 ± 0.3 (0.2)

8 ± 0.2 (0.1)

/8 ± 0.5(0.3)

5.5 ± 0.5(0.3)

3 ± 0.2 (0.1)

/8 ± 0.4 (0.2)

3 ± 0.2 (0.1)

/7 ± 0.1 (0.1)

After

4.5 ± 0.5(0.3)

4.5 ± 0.5(0.3)

/5 ± 0.2 (0.1)

5 ± 0.2 (0.1)

/11 ± 0.4 (0.2)

5 ± 0.5(0.3)

/11 ± 0.2 (0.1)

9 ± 0.2 (0.1)

/10 ± 0.3 (0.2)

6.5 ± 0.3 (0.2)

5 ± 0.1 (0.1)

/10 ± 0.2 (0.1)

5 ± 0.5(0.3)

/10 ± 0.1 (0.1)

% of change

33.3

33.3

/40

40

/18.2

40

/22.3

11.1

/20

15.4

40

/20

40

/30

(p-value)

0.011*

0.021*

/ <0.001**

<0.001**

/ <0.001**

0.003*

/ <0.001**

0.004*

/0.004*

0.041*

<0.001**

/ <0.001**

0.003*

/ <0.001**

13/ Enterobacter cloacae

Before

4 ± 0.1 (0.1)

3 ± 0.2 (0.1)

/3 ± 0.5(0.3)

7 ± 0.1 (0.1)

/11 ± 0.4 (0.2)

6 ± 0.2 (0.1)

/11 ± 0.4 (0.2)

6 ± 0.2 (0.1)

/6 ± 0.1 (0.1)

10 ± 0.2 (0.1)

7 ± 0.1 (0.1)

/12 ± 0.2 (0.1)

6 ± 0.1 (0.1)

/10 ± 0.2 (0.1)

After

4 ± 0.5(0.3)

4 ± 0.1 (0.1)

/4 ± 0.3 (0.2)

8.5 ± 0.4 (0.2)/13 ± 0.2 (0.1)

6.5 ± 0.1 (0.1)

/12 ± 0.1 (0.1)

6 ± 0.2 (0.1)

/7 ± 0.3 (0.2)

12 ± 0.3 (0.2)

8.5 ± 0.1 (0.1)

/14 ± 0.2 (0.1)

6.5 ± 0.2 (0.1)/10.5 ± 0.3 (0.2)

% of change

0.0

25

/25

17.6

/15.4

7.5

/8.3

0.0

/14.3

16.7

17.6

/14.3

7.5

/4.8

(p-value)

1.000

<0.001**

/ 0.041*

0.003*

/ <0.001**

0.018*

/0.014*

1.000

/0.005*

<0.001**

<0.001**

/ <0.001**

0.018*

/0.074

  1. DDST Double disk synergy test, MDDT Modified double disk synergy test p-value significant <0.05
  2. AMC (20/10 μg) = Amoxicillin /clavulanic Acid CTX (30 μg) = Cefotaxime p-value non significant > 0.05
  3. CAZ (30 μg) = Ceftazidime FEP (30 μg) = Cefepime p-value highly significant <0.001**
  4. ATM (30 μg) = Aztreonam TZP (100/10 μg) = Piperacillin / tazobactam